CellaVision AB (publ) Overview
Latest ROE for CellaVision AB (publ): 14.67% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow14.67%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
CellaVision AB (publ) (CLVSF) currently reports a ROE of 14.67%. That is above the sector sector average of 11.75%. Use the charts on this page to explore CellaVision AB (publ)'s ROE history and peer comparisons.
CellaVision AB (publ)'s ROE of 14.67% is higher than the its sector sector average of 11.75%. That is roughly 24.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but CellaVision AB (publ)'s current 14.67% should be judged against industry norms (sector average: 11.75%) and against CLVSF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 14.67%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.75%. From there, open related valuation or income-statement pages for CellaVision AB (publ), and consider following CLVSF for alerts when major investors trade the stock.
